Chemical Biology Strategies for Posttranslational Control of Protein Function  by Rakhit, Rishi et al.
Chemistry & Biology
ReviewChemical Biology Strategies
for Posttranslational Control of Protein FunctionRishi Rakhit,1 Raul Navarro,1 and Thomas J. Wandless1,*
1Department of Chemical & Systems Biology, Stanford University, Stanford, CA 94305, USA
*Correspondence: wandless@stanford.edu
http://dx.doi.org/10.1016/j.chembiol.2014.08.011
A common strategy to understand a biological system is to selectively perturb it and observe its response.
Although technologies now exist to manipulate cellular systems at the genetic and transcript level, the direct
manipulation of functions at the protein level can offer significant advantages in precision, speed, and revers-
ibility. Combining the specificity of genetic manipulation and the spatiotemporal resolution of light- and
small molecule-based approaches now allows exquisite control over biological systems to subtly perturb
a system of interest in vitro and in vivo. Conditional perturbation mechanisms may be broadly characterized
by change in intracellular localization, intramolecular activation, or degradation of a protein-of-interest. Here
we review recent advances in technologies for conditional regulation of protein function and suggest further
areas of potential development.Mechanistic understanding of cell biology and physiology is
driven in part by the tools available to manipulate the system
and to assay the phenotypic response. The study of a particular
process requires specialized approaches to enable dissection of
components, connectivity, and, ultimately, causation. A wide
variety of molecular techniques are now available to examine
processes at different length scales and levels of biological
complexity. Understanding the mechanistic underpinnings
requires the ability to selectively alter specific structural or
functional elements in order to gauge their phenotypic conse-
quences. Successive technological advances allow interroga-
tion of the system under study with greater precision while
minimizing off-target perturbation. Wide adoption of a technique
also requires it to be robust, low cost, and relatively easy to use.
Although there have been many advances in the ability to
observe cells and especially intact organisms (Dean and Palmer,
2014; Sinha et al., 2013), here we focus on the control of
individual genes in order to understand their function in specific
contexts.
One of the fundamental ways to deduce the role of a gene is to
increase or decrease its function andobserve the response of the
system. Current strategies can target each step in the conversion
of a gene into its functional product, mimicking natural control
processes of the central dogma (Figure 1). Generally speaking,
genetic techniques targeting DNA are robust and specific but
have been difficult to implement, slow, and poorly reversible.
Site-specific genomic editing by homologous recombination is
robust in certain model organisms but until recently has been
hampered by very low efficiency in mammalian systems. Homol-
ogous recombination or loss-of-function mutations can be
stimulated using site-specific double-strand breaks using zinc-
finger nucleases, transcription activator-like effector nucleases
(TALENs), or clustered regulatory interspaced short palindromic
repeat (CRISPR)-Cas9 (Cheng and Alper, 2014). Control over
RNA stability through RNAi is faster and easier to implement
than traditional DNAmanipulation techniques, though it is limited
by the efficiency of knockdown and the possibility of off-target
effects (Milstein et al., 2013). Each of these also acts indirectly1238 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Lton the functional molecule. Directly targeting proteins via small-
molecule inhibitors or activators is fast, conditional, and simple
if a perturbant is available but may be limited by specificity and
exhibit off-target effects (Fabian et al., 2005; Lounkine et al.,
2012). Each of these technologies is generalizable to the study
of many or all genes but may work better or worse for particular
genes, in different organisms or cell types. For example, studying
essential genes requires conditional techniques in order to prop-
agate cells and allow organismal development.
Experimental Considerations for Choice in Perturbation
Technique
Thechoice of experimental strategy (or combination of strategies)
is typically a trade-off between precision requirements and ease
of use (summarized in Tables S1 and S2). A perturbation strategy
has a number of desirable attributes. Ideally, the technique
should be: (1) specific, (2) robust, (3) conditional, (4) efficient, (5)
reversible, (6) tunable, (7) rapid, (8) orthogonal, (9) spatially local-
ized, (10) simple, and (11) low cost. From a pragmatic standpoint,
technologies requiring several geneticmanipulations, specialized
microscopes, or custom synthesized small-molecule reagents
increase the barrier to entry and limit both the adoption of new
technologies and their use to low-throughput modes.
From a scientific standpoint, the perturbation should be spe-
cific; that is, the intervention should minimize unwanted side
effects, especially unforeseen ones that are difficult to control
for. This is especially a concern for RNAi, in which validation
using independent small interfering RNAs (siRNAs) targeting
the same gene is required, or for poorly characterized small mol-
ecules, especially those that must be used at high concentra-
tions, which may bind to proteins other than the desired target.
The perturbation strategy should also be robust; that is, it should
be readily usable without requiring extensive validation and opti-
mization and additionally should yield consistent and reproduc-
ible results. Conditional strategies allow a trigger to enact the
modification of interest, which can be required when studying
essential genes or when themodification is desired in only a sub-
set of an organism’s cells.d All rights reserved
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Figure 1. Comparison of Naturally Occurring and Synthetic Engineered Control Processes
(A) The central dogma of molecular biology governs the transcription of DNA (genome) into mRNA (transcriptome), which is then translated into proteins. Every
step is regulated by processes, some of which are listed here above the relevant step in the flow of information from DNA into proteins. Engineered experimental
perturbation strategies mimic various natural regulatory steps, some of which are shown here.
(B) Protein activity is regulated intracellularly by a variety of processes, including its availability in a particular subcompartment, whether it is part of a complex, its
tertiary structure and dynamics, and its abundance. Each of these strategies is exploited experimentally for conditional posttranslational control of protein
function.
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from residual amounts of remaining active protein from ineffi-
cient knockdown in RNAi, leaky expression from transcriptional
control strategies, or incorrectly localized or undegraded pro-
tein. Alternately, being able to reversibly and tunably regulate a
protein-of-interest allows facile study of whether the observed
phenotype is specific to the gene being studied and opens up
quantitative studies. Rapidity must be measured relative to the
speed of the process being studied but at minimum should avoidChemistry & Biology 2conflating adaptive responses to a protein being depleted, over-
expressed, or activated. In particular, different technologies for
posttranslational control may act by turning on (e.g., inteins)
or turning off (destabilization domains) protein activity and rely
on natural, slow mechanisms in the other direction; care should
be taken to choose a technique when observing a biological
phenomenon requiring a gain of function, for which rapidly
increasing protein activity is desirable, or a loss-of-function, for
which rapidly decreasing a protein’s activity may be required.1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1239
Chemistry & Biology
ReviewIt may at times also be desirable to manipulate several genes
simultaneously; these should be orthogonal to one another in
addition to the biological system. Ideally, the technology would
allow temporal and spatial precision within the physiological
context.
Awell-characterized small molecule hasmany of the attributes
listed above. Small molecules act rapidly in comparison with ge-
netic perturbation tools, can tunably modulate protein activity,
and can reversibly bind a protein target. However, their speci-
ficity is not guaranteed: many small molecules are known to
interact with more than one protein target (Gaulton et al.,
2012). Additionally, the vast majority of genes and proteins do
not have high-affinity small-molecule binding partners.
Combining genetic and chemical perturbation (often called
‘‘chemical genetics’’) allows researchers to potentially take
advantage of the specificity of genetic techniques with the speed
and reversibility of small-molecule-based approaches (Banas-
zynski and Wandless, 2006). Typically, a genetic fusion is
made between an effector molecule and a small-molecule-
dependent control module and expressed exogenously on either
a wild-type or mutant loss-of-function background. These con-
trol elements may act directly on the protein-of-interest, indi-
rectly to control gene expression, and so on. Recent advances
in genomic targeting through TALENs or CRISPR-Cas9 have
made tagging of endogenous alleles possible, though it still re-
quires weeks to months of effort (Dean and Palmer, 2014; Gaj
et al., 2013). This allows the control of a protein-of-interest
without competition from endogenous proteins. Chemical ge-
netic strategies using bio-orthogonal ligands, small molecules
that are minimally perturbing to the biological system being
studied, should be used whenever possible in order to minimize
off-target effects; however, expediency, availability, and famil-
iarity often compel researchers to use rapamycin-based dimer-
izer systems or other small-molecule ligands that are known to
not be biologically silent (Edwards and Wandless, 2007).
Several situations would also demand spatial regulation of
protein function; localization of a ubiquitously expressed protein
could affect its function, the protein-of-interest may be active
only in a certain subcellular compartment or, on a longer length
scale, genes in subcompartments of tissues could be controlled.
Within metazoans, cell-specific activation can be accomplished
through tissue-specific promoters or activators, but specificity is
dictated by the underlying biological specificity of the chosen
promoter or enhancer (Kistner et al., 1996). An alternative would
be to control spatial activity with light. Use of light rather than a
small molecule as the control element offers a number of advan-
tages. Although perfusion setups can limit the diffusion of small
molecules, light-mediated activity is not limited as such (Taylor
et al., 2010). Activation and inactivation kinetics of light-medi-
ated approaches can be fast and do not require media changes.
On the other hand, spatially targeting a light beam often requires
specialized microscopes and software (Wu et al., 2009). Unless
spatial regulation is strictly required, small-molecule approaches
still offer advantages in not requiring continuous application of
the light, which may cause phototoxicity and local heating and
limit throughput.
Chemical genetic approaches, including those regulated by
light, can act directly on gene expression by targeting the pro-
tein-of-interest or indirectly by altering the gene or transcript.1240 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier LtSmall-molecule-dependent transcription, through either fusion
of the tetracycline or estrogen receptor ligand binding domain
to sequence specific transactivator domains, has been widely
adopted for conditional regulation (Banaszynski and Wandless,
2006; Kistner et al., 1996). Although significant improvements
to lowering transcription in the absence of activating drug have
been made, transcriptional approaches still face the funda-
mental limitations in waiting for the natural clearance of the
protein-of-interest from the cell and, practically, in the lack of
predictably tunable gene expression. Here, we focus on post-
translational control of protein function to overcome these limita-
tions, because the protein-of-interest is targeted directly. The
historical and foundational groundwork for these technologies
is covered in earlier reviews (Banaszynski and Wandless,
2006); recent advances and applications are emphasized here.
Strategies for posttranslational control of protein function can
be classified by their modes of action (Figure 1B). First, because
the biological activity of a protein-of-interest is often limited to a
specific subcompartment of the cell, altering its localization can
control its activity. Small molecules or light can be used to
change the location of the protein within the cell, in order to either
activate it or inactivate it. This is usually accomplished by dimer-
ization of the protein-of-interest with other proteins known to be
localized to the desired cellular compartment. Conditional (mis)
localization is often very fast, but its use is limited to those pro-
teins that have compartment-specific activity. Second, a pro-
tein-of-interest can be activated or inhibited directly without
changing its physical abundance in the cell. This can be accom-
plished through a variety of both intermolecular and intramolec-
ular mechanisms, discussed below. Last, because a protein
cannot exert its activity if it does not exist, several approaches
to reduce a protein’s function by altering its intracellular stability
are discussed.
Conditional Dimerization: (Mis)localization
One of themost commonly used strategies to conditionally regu-
late protein activity involves promoting the association of any
two proteins-of-interest. Over the past two decades, small mol-
ecules have emerged as effective means by which to engineer
such protein-protein interactions. These compounds, commonly
referred to as chemical inducers of dimerization (CIDs), have the
ability to simultaneously bind two protein domains, thereby
inducing their proximity. As illustrated in the following discus-
sion, CIDs have been used to mediate protein activity in one of
three ways: by promoting transcriptional activity, by recruiting
target proteins to specific cellular compartments, or by facili-
tating protein aggregation and disaggregation (Figure 2).
The first example of a naturally occurring CID was described in
1991, when the immunosuppressant drug FK506 was reported
to inhibit T cell receptor-mediated signaling by simultaneously
binding FK506-binding protein (FKBP12) and calcineurin (Liu
et al., 1991). On the basis of these seminal findings, a synthetic
dimer of FK506 (named FK1012) was prepared, which was
able to dimerize FKBP12 (Spencer et al., 1993). Fusion of the
FKBP12 domain to the z chain of the T cell receptor resulted in
chimeras that exhibited FK1012-dependent signal transduction
in cultured cells. Notably, FK1012-induced signaling was found
to be rapid, dose dependent, and reversible. In addition, the syn-
thetic ligand lacked its parent monomer’s intrinsic biologicald All rights reserved
Figure 2. Subcellular Localization as a Strategy to Control Protein
Function
Upon translation in the cytoplasm, a protein’s activity can be controlled by the
availability of its substrates. CIDs have been used both to trigger protein ac-
tivity by recruitment to its site of action, such as at the plasma membrane or in
the nucleus, and to be inactivated by its aggregation or sequestration in a
subcellular compartment where it cannot act.
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used to stimulate the activity of transcription factors (Ho et al.,
1996), induce Fas-mediated apoptosis (Belshaw et al., 1996a),
and activate the Raf1-kinase signaling cascade (Farrar et al.,
1996).
Although the FK1012 systemwas the first to chemically induce
the proximity of engineered proteins, its utility is most suitable for
proteins whose function is dependent on homodimerization. In
1996, several bivalent molecules capable of selectively dimeriz-
ing two different proteins were reported (Belshaw et al., 1996b;
Licitra and Liu, 1996; Rivera et al., 1996). Among these, rapamy-
cin represents the most thoroughly studied chemical dimerizer.
This macrolide natural product mediates the interaction between
FKBP12 and the FRB domain of FKBP-rapamycin associated
protein (mTOR) (Brown et al., 1994). Expression of two pro-
teins-of-interest as their FKBP and FRB fusions results in their
rapamycin-inducible association. Rapamycin facilitates FKBP-
FRB complexation on the order of minutes, has low nanomolar
affinity for both protein domains, and exhibits good pharmacoki-
netics (Banaszynski et al., 2005). However, FKBP and FRB fusion
proteins compete with endogenous FKBP and mTOR for rapa-
mycin binding, leading to nonproductive interactions. Moreover,
the binding and inhibition of mTOR leads to cell-cycle arrest,
further complicating in vivo studies, though rapamycin resistant
strains or cell lines may be used to mitigate these effects (Haruki
et al., 2008). In order to mitigate its off-target effects, rapamycin
was derivatized to display a ‘‘bump’’ at its FRB-binding interface
(Liberles et al., 1997). Site-directed mutagenesis of the FRB
domain delivered a triple mutant, FRB*, bearing a compensatoryChemistry & Biology 2‘‘hole’’ that selectively binds the new rapamycin analog (MaRap).
Although this modified dimerization system does not possess
immunosuppressive activity, MaRap is unstable, is difficult to
prepare, and exhibits poor pharmacokinetic properties, preclud-
ing in vivo applications (Stankunas et al., 2003).
The ‘‘bump and hole’’ strategy has also been applied to
develop FKBP mutants that have high affinity for other biologi-
cally silent rapamycin mimics. Interestingly, introduction of a
single point mutation (F36M) in the FKBP active site affords a
variant (FKBP*) that spontaneously undergoes multimerization
in the absence of its cognate ligand, AP21998 (Rollins et al.,
2000). The FKBP* aggregate could be readily dissociated upon
addition of the small molecule, providing a peculiar example of
a reverse dimerization system. Fusion of tandem copies of
FKBP* to a protein-of-interest generates a protein target that
self-associates and displays AP21998-dependent disaggrega-
tion. This tool was first applied to conditionally control protein
secretion: when insulin is properly tagged with a signal peptide,
an FKBP* tetramer, and a furin protease cleavage site, the
chimeric protein undergoes aggregation in the endoplasmic re-
ticulum and becomes too large to be properly exported (Rivera
et al., 2000). Exposure to AP21998 releases monomeric insu-
lin-FKBP* fusions and allows for their export via the secretory
pathway, during which the furin protease cleaves the FKBP*
domain to release free insulin. More recently, Arnold and col-
leagues exploited the FKBP* conditional secretion system to
monitor the trafficking of cargo from the endoplasmic reticulum
to the Golgi and subsequently the plasma membrane in neurons
(Al-Bassam et al., 2012). This ‘‘pulse-chase’’ system allowed
them to differentiatemodes of axonal and dendritic vesicle trans-
port and discriminate between competing transport models.
The more recent characterization of new protein-ligand pairs
has led to the development of other CID systems. For example,
Cornish and coworkers used a dexamethasone-methotrexate
(Dex-Mtx) conjugate to induce the interaction between glucocor-
ticoid receptor (GR) and dihydrofolate reductase (DHFR) (Lin
et al., 2000). Coexpression of the yeast DNA-binding domain
of LexA and the transcriptional activation domain of B42 as their
DHFR and GR fusions, respectively, stimulated transcription of
the lacZ reporter gene in the presence of Dex-Mtx. Unfortu-
nately, Mtx is a promiscuous inhibitor of DHFR, which limits its
broader utility. An improved system that uses a trimethoprim-
SLF dimerizer was developed, a bivalent ligand that triggers
the interaction between E. coli DHFR-FKBP12 fusions (Czlapin-
ski et al., 2008). Importantly, this compound was not found to
bind endogenous protein targets and has been used to condi-
tionally activate a mammalian fucosyltransferase.
Despite its cytotoxic properties, rapamycin continues to be
the most widely implemented CID. To control the activity of
essential proteins in yeast, two studies used a strategy by which
nuclear proteins can be conditionally sequestered to the cyto-
plasm, where they can no longer perform their cellular functions
(Geda et al., 2008; Robinson et al., 2010). In practice, this tech-
nique achieves rapamycin-mediated mislocalization by geneti-
cally tagging a nuclear protein and a cytoplasmic anchor protein
with FRB and FKBP, respectively. To function properly, a suit-
able anchor was envisioned to be highly abundant protein
domain that traffics in and out of the nucleus, so that it transiently
encounters the target. The ribosomal subunit RPL13A ultimately1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1241
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shuttle more than 40 essential nuclear proteins to the cytoplasm
in a rapamycin-dependent manner, leading to loss-of-function
mutant phenotypes. Although this method has proved useful
in rapidly generating conditional knockouts, it also presents
several limitations. First, these studies necessitated the use of
rapamycin-resistant strain of yeast to circumvent inhibition of
TOR. More important, it remains unclear how the current system
can be employed to mislocalize and regulate cytoplasmic pro-
teins; in principle, targeting a cytoplasmic protein to the nucleus
or plasma membrane may inactivate it, though this must be
tested on a case-by-case basis. Toward this goal, a recent study
demonstrated that an FKBP-tethered adaptor protein-1 complex
undergoes rapamycin-mediated localization to mitochondria
when coexpressed with FRB fused to a mitochondrial targeting
sequence. Robinson and colleagues were able to achieve fast
(approximately minutes) reduction in the activity of several
proteins in the endocytosis pathway. Importantly, the rapidity
of the ‘‘knock-sideways’’ system allowed the researchers to
observe a phenotype distinct from siRNA-mediated knockdown
of the same protein, an effect they attributed to compensatory
responses from slow knockdown (Robinson et al., 2010). Alter-
natively, sequestration does not necessarily require targeting
to a subcellular compartment at all. Heo and colleagues recently
showed that simply multimerizing and clustering a protein
through is sufficient to reduce its activity without limiting its sub-
cellular localization (Lee et al., 2014).
Despite their general utility, the CIDs discussed thus far are not
without limitations. Many of these small molecules are expensive
and require multistep syntheses, which can restrict their acces-
sibility. In addition, their application in live animals is often
impeded by their promiscuous binding profiles and/or affinity
for endogenous proteins, interactions that often lead to cytotoxic
effects. Moreover, given the nanomolar affinity between each of
these ligand-protein pairs, the reversibility of their association is
typically contingent upon the addition of a second, high-affinity
ligand to displace the bivalent molecule. For example, rapamy-
cin-mediated FKBP-FRB dimerization can often be reversed by
the addition of exogenous FK506, which competitively binds
the FKBP active site. In some instances, rapamycin-induced
proximity is irreversible (Haruki et al., 2008).
To address these challenges, researchers have exploited
small-molecule-mediated signaling pathways that have recently
been characterized in plants. One such pathway involves absci-
sic acid (ABA), a hormone that stimulates several components of
plant development. Mechanistically, ABA inhibits type 2Cprotein
phosphatases (PP2Cs) by mediating their association with the
pyrabactin resistance (PYR)/PYR1-like (PYL) family of protein re-
ceptors (Cutler et al., 2010). In 2011, Crabtree and coworkers
designed PYL and PP2C domains that, when individually fused
to proteins-of-interest, can reconstitute Gal4 transcriptional
activity, localize protein targets to the nucleus or cytoplasm,
and induce extracellular signal-regulated kinase phosphoryla-
tion in mammalian cells upon exposure to ABA (Liang et al.,
2011). This plant-specific hormone is inexpensive, does not
bind endogenous mammalian proteins, and was found to be
nontoxic to cultured cells and mice. However, high micromolar
concentrations of ABA are necessary to induce PYL/PP2C prox-
imity. Nevertheless, this interaction is more readily reversible1242 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltthan the corresponding ternary interaction mediated by rapamy-
cin: upon ABA washout, protein activity was reduced to basal
levels within 24 hr.
Notably, the addition of plant-based dimerizers to the standing
collection of CIDs presents an interesting opportunity to regulate
the activity of multiple protein signaling pathways. Specifically,
use of a plant dimerizer in concert with a rapamycin-inducible
system could allow for the simultaneous and orthogonal control
of two different proteins. The net result would be a synthetic logic
gate, wherein defined cellular output results from each of the
small-molecule inputs. Inoue and coworkers examined the feasi-
bility of such a dual-proximity system by first engineering a CID
on the basis of a different plant hormone, gibberellin (GA3)
(Miyamoto et al., 2012). To exert its effects, GA3 facilitates the
interaction between gibberellin-insensitive dwarf1 (GID1) and
gibberellin insensitive (GAI) (Hirano et al., 2008). After optimiza-
tion of gibberellin (GA3-AM) and the GID1-GAI domains, the
authors constructed intracellular AND and OR logic gates using
changes in cell morphology as the phenotypic output signal. For
the OR gate, FKBP, GID1, and YFP were fused to Tiam1, a gua-
nine nucleotide exchange factor that activates Rac1 and results
in membrane ruffling when it is recruited to the plasma mem-
brane. Coexpression of the Tiam1 fusion and the membrane-
targeted Lyn-CFP-FRB-GAI in mammalian cells led to significant
membrane ruffling only the presence of GA3-AM, rapamycin, or
both chemical inputs. Importantly, both small molecules can
facilitate Tiam1 membrane recruitment on the order of seconds
to minutes. Unfortunately, the dissociation kinetics for both sys-
tems remain relatively slow. Moving forward, orthogonal CIDs
that exhibit fast on and off kinetics will greatly improve the use
of logic gates in live cells.
Mislocalization by Light-Mediated Dimerization
The current palette of chemical dimerization systems has
allowed researchers to tunably and reversibly regulate a number
of protein-protein interactions on the order of minutes to hours.
In contrast, protein signaling pathways in living cells typically
occur on a second timescale, a time frame that is difficult to
recapitulate using small molecules. Additionally, specific subcel-
lular localization of a CID cannot always be achieved, a property
that further limits their potential applications. In order to signifi-
cantly improve the spatiotemporal precision of these tools,
recent efforts have turned to the use of light to control the asso-
ciation of two proteins-of-interest. In particular, several studies
have taken advantage of naturally occurring photosensitive pro-
tein domains that undergo a dimerization event when exposed
to a specific wavelength of light. An additional advantage with
light-controlled systems is that they do not typically require the
addition of an exogenous ligand, mitigating the potential for
off-target or toxic effects.
The most commonly used photoswitchable domains take
advantage of light-sensitive signaling proteins identified in the
flowering plant Arabidopsis thaliana. One such protein is exem-
plified by phytochrome B (PhyB): upon irradiation with red light
(650 nm), PhyB undergoes a conformation change and binds
phytochrome interaction factor 3 (PIF3), resulting in transcrip-
tional activation (Ni et al., 1999). Exposure of this complex to
750 nm light reverses this interaction, such that PhyB no longer
has significant binding affinity for PIF3. To determine the abilityd All rights reserved
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mammalian cells were cotransfected with constructs encoding
a plasma membrane-anchored PhyB and a PIF3-tagged Tiam1
(Levskaya et al., 2009). Irradiation of these cells at 650 nm results
in membrane recruitment and activation of Tiam1 within sec-
onds, leading to lamellipodia formation. Interestingly, focusing
a red laser at precise cellular locations stimulated localized pro-
trusions that could be patterned at will, providing a handle by
which to precisely control cell morphology. The PhyB-PIF inter-
action was recently adapted to develop a photoswitchable
anchoring system in yeast (Yang et al., 2013). By fusing PhyB
to different organelle-targeting sequences, a PIF3-tagged
protein target could be conditionally recruited to eight distinct
subcellular locations, including endosomes, peroxisomes, the
nucleus, and the spindle pole body. This strategy is conceptually
similar to the rapamycin-based anchoring system discussed
above but offers faster association kinetics and is readily revers-
ible. Notably, the spatiotemporal precision imparted by this
approach allowed the authors to dissect the multifunctional
role of Clb2, amitotic cyclin found to be critical for proper nuclear
fission and spindle pole body disassembly. A caveat to this strat-
egy is that it requires the addition of phycocyanobilin, a ligand
that mediates the PhyB allosteric transition.
To eliminate the need for exogenous cofactors, a second pair
of photosensitive dimerizers was established. In this case, the
blue light-dependent interaction between the A. thaliana FKF1
protein and GIGANTEA (GI) (Sawa et al., 2007) was harnessed
to conditionally activate Rac signaling and activate the Gal4
transcription factor (Yazawa et al., 2009). In contrast to the
PhyB-PIF system, photoexcitation of FKF1 triggers a conforma-
tional change controlled by flavin mononucleotide, a cofactor
that is naturally produced by mammalian cells. Unfortunately,
FKF1 and GI fusion proteins exhibit blue light-induced associa-
tion on the timescale of minutes and required more than 1.5 hr
to dissociate once illumination is ceased. Tucker and coworkers
recently implemented a new pair of photosensitive domains with
improved on/off kinetics on the basis of cryptochrome 2 (CRY2)
and cryptochrome-interacting basic-helix-loop-helix 1 (CIB1)
(Kennedy et al., 2010). When optimized in mammalian cells,
photo-stimulated CRY2-CIB1 association was observed to
occur within 300 ms, but the reverse process took minutes to
complete. This represents the first system that achieves dimer-
ization on a subsecond timescale. Ideally, the association and
dissociation kinetics of the dimerization domains would occur
on similar timescales; however, no such systems have been re-
ported to date.
An indirect approach to light-induced proximity involves
genetically incorporating a photosensory domain into a peptide,
such that the peptide’s affinity for its cognate protein is rendered
dependent on light. Fusion of the modified peptide and its bind-
ing partner to proteins-of-interest affords targets that then
exhibit light-dependent association. Two studies independently
created photoswitchable peptides on the basis of the light, oxy-
gen, or voltage (LOV2) domain of Avena sativa phototropin1
(Strickland et al., 2012; Lungu et al., 2012). LOV2 comprises a
PAS domain that bears a C-terminal a helix (Ja), which remains
docked to the PAS fold in the dark state. Photoexcitation with
blue light facilitates Ja unfolding and dissociation from the LOV
core. Vinculin-binding (Lungu et al., 2012) and PDZ-bindingChemistry & Biology 2(Strickland et al., 2012) peptides were engineered into the Ja
helix, such that the peptide was caged in the dark state and
accessible to its binding partner in the lit state. LOV2-based
technologies benefit from the fact that the LOV2-Ja interaction
is biophysically well characterized, allowing a more predictable
modulation of this dimerizer’s dynamic range.
Taken collectively, the intensive research behind conditional
dimerization has culminated in the development of tools that
operate at the second timescale, localize targets with high
spatial resolution, and are biologically orthogonal. Whether small
molecule or light based, many of these approaches are still
in their infancy, and each presents its own drawbacks. For
example, light-mediated dimerization systems often display
limited localization differences in the lit versus dark state; from
published data, the CRY2 system appears to have the best
signal-to-noise ratio (Kennedy et al., 2010), but smaller fold dif-
ferences may nonetheless be useful in interrogating biological
systems, as Yang et al. (2013) demonstrated in elucidating the
spatiotemporal role of Clb2 activity in the cell cycle. It will be
interesting to take note of their future applications in elucidating
the mechanisms of complex signaling pathways. Within this
context, the combination of small-molecule- and light-based
approaches to simultaneously mediate more than one protein-
protein interaction may facilitate the construction of artificial
signaling networks. Although rapamycin-based approaches
continue to serve as the dimerization modules of choice, in-
depth studies of more recently developed proximity tools—
such as improvements in their on/off kinetics and more thorough
biophysical characterization of the dimerization domains—
should facilitate their widespread use.
Activation of Preproteins
Rather than controlling protein activity by localization to a spe-
cific cellular compartment, an alternative approach relies on
splitting a protein-of-interest into two inactive fragments. When
properly engineered, these fragments can be induced to asso-
ciate, thereby restoring the target’s structure and cellular func-
tion. This process, also known as fragment complementation,
was first combined with chemical dimerization tools in 2002
(Mootz and Muir, 2002) (Figure 3). In this study, Muir and
coworkers developed a conditional protein splicing system
based on inteins, protein domains that catalytically excise them-
selves from a polypeptide chain and simultaneously ligate their
two flanking sequences. Specifically, the Saccharomyces cere-
visiae VMA intein was split into N- and C-terminal halves: the
former was fused between FKBP and maltose-binding protein
(MBP) and the latter between FRB and a His tag. Rapamycin-
induced dimerization of these fusions induced the proximity of
the intein domains, which restored intein splicing activity and
led to the formation of a His-tagged MBP.
This exploratory study illustrated that intein activity could be
manipulated to conditionally tag a protein with a small peptide.
In order to control the activity of a split protein, Liu and
coworkers took a directed evolution approach to design a
conceptually similar intein splicing system (Buskirk et al.,
2004). In this case, the estrogen receptor-binding domain (ER)
was initially inserted into an intein to give an inteinN-ER-inteinC
fusion that lacked splicing activity. A library of intein candidates
was prepared by error-prone PCR, then cloned between the1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1243
Figure 3. Conditional Dimerization Rescues
Protein Function
(A) Proteins that require dimerization to function
(e.g., transcription factors, some enzymes) can be
activated directly by hetero- or homodimerization.
(B) Regulated protein fragment complementation.
The protein’s primary sequence is split into two
pieces, each of which is fused to a dimerization
domain. Dimerization allows reconstitution of the
holoprotein.
(C) Split inteins. Self-excising intein protein do-
mains can be fusedwith the split protein fragments
to allow complementation of the protein-of-inter-
est. Upon intermolecular excision and ligation of
the intein, the extein fragments are fused to form a
single active polypeptide with no intervening
dimerization domains.
(D) Expressed protein ligation. Similar to split
inteins, except that one of the fragments is syn-
thetically derived. This can be especially useful to




ReviewN- and C-terminal portions of the KanR gene. Mutants that ex-
hibited ligand-dependent splicing were identified by their ability
to confer Geneticin resistance in the presence of 4-hydroxyta-
moxifen (4-HT), a high-affinity ER ligand. Additional rounds of
selection delivered an evolved intein that could restore the activ-
ity of four different proteins in a 4-HT-dependent fashion.
Although originally devised in yeast, improved mutants allowed
this 4-HT-dependent intein splicing to also be used in mamma-
lian cells (Peck et al., 2011). Alternatively, split inteins’ function
can be controlled via dimerization of the two halves using
small-molecule rapamycin-FKBP-FRB (Schwartz et al., 2007),
light-based PhyB dimerization (Tyszkiewicz and Muir, 2008), or
protein-based coiled-coil-based dimerization (Selgrade et al.,
2013) systems.
A major drawback of intein-based fragment complementation
systems is their lack of reversibility. Intein splicing is an inherently
irreversible process, and it is difficult to imagine how one might
alter this mode of reactivity to inactivate the extein product.
One solution to this problem involves fusing each of a protein’s
fragments directly to a pair of dimerization domains, such that
the activity of the engineered protein is dependent solely on
ligand-induced proximity. On a more general level, these
approaches require researchers to judiciously determine how
to best separate their protein target into two halves without
creating disordered polypeptides that are not metabolically sta-
ble. Consequently, such studies often require a systematic
screen of various N- and C-terminal fragment pairs, which can
become laborious and requires optimization on a case-by-
case basis. Depending on the protein-of-interest, it may prove
difficult or impossible to split the target in such a way that main-
tains its structural and functional integrity.
Intein mechanisms have also been exploited to produce
caged semisynthetic proteins by expressed protein ligation1244 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltd All rights reserved(Muir et al., 1998). Again, a protein-of-
interest is judiciously split into an ex-
pressed fragment and a shorter peptide
containing important functional residues.
Conditional protein activity can beachieved by functionalizing key residues in the synthetic peptide
with light-dissociable 2-nitrobenzyl leaving groups followed by
incorporation of this peptide into the full-length protein by ex-
pressed protein ligation. This strategy allowed, for example,
the Imperiali group to produce caged myosin protein with excel-
lent spatial and temporal control profiles (Goguen et al., 2011).
This approach, however, currently requires microinjection of
the semisynthetic protein that has been produced in vitro, and
the general availability of these reagents may be limited. In the
future, direct protein transfection with supercharged proteins
may be possible (McNaughton et al., 2009).
In attempting to develop a general fragment complementation
system, Ghosh and coworkers designed kinases that could
tolerate small loop insertions in their catalytic domain without
compromising their catalytic activity (Camacho-Soto et al.,
2014). Insertions were deliberately incorporated into regions of
the catalytic domain of several tyrosine kinases that shared little
sequence homology, suggesting that these regions were not
essential for activity. The insertion then served as a flexible handle
through which a kinase could be fragmented into two domains
and fused to FKBP and FRB. This strategy was used to develop
split versions of Lyn, Fak, and Src kinases, and the AGC kinase
PKA, all of which exhibit rapamycin-inducible activation.
Engineered Proteins for Orthogonal Small-Molecule
Control
As has been discussed, small-molecule inhibitors and activators
offer fast, tunable control over proteins-of-interest when avail-
able. An alternative to finding a specific small molecule for
each protein-of-interest is using a functionalized substrate
analog approach coupledwithmutation in the protein-of-interest
in order to accept the functionalized analog. This strategy has
been used in a variety of contexts, including for guanosine
Figure 4. The ‘‘Bump-Hole’’ Strategy
The protein-of-interest is mutated to create a
cavity so that it will accept both the natural sub-
strate and a larger substrate analog. The substrate
analog will bind only to the engineered mutant
protein. The substrate analog can either be an in-
hibitor, to selectively inhibit themutant protein, or it
can add a novel functionality, so the enzyme’s
target is unnaturally modified, which can then be
exploited for purification of its targets.
Chemistry & Biology
Reviewtriphosphate (GTP)-binding proteins, seven-pass transmem-
brane proteins, and perhaps most generally for protein kinases
(Bishop et al., 2000a, 2000b) (Figure 4). The so-called bump-
hole strategy, pioneered by the Shokat group, uses a ‘‘bumped’’
substrate analog possessing bulky side-chain substituents that
have greatly reduced binding to wild-type kinases but bind
with high affinity to kinaseswith amutation in the gatekeeper res-
idues to produce a complementary ‘‘hole.’’ When expressed in
cells, the mutant kinase can be specifically inhibited by the addi-
tion of the bumped inhibitor.
Importantly, the bump-hole strategy seems readily generaliz-
able to an arbitrary protein kinase of interest whereby the
compensatory mutation can be identified using homology
searching. In cases in which the hole-forming mutation is desta-
bilizing, additional compensatory stabilizing mutations can be
found (Zhang et al., 2005). In addition to its use as a control
element, mutated kinases can also accept derivatized sub-
strates to selectively tag their target proteins. Using this
approach, Shokat, Morgan, and coworkers were able to identify
targets of the S. cerevisiaeCdk1 homolog Cdc28 (Ubersax et al.,
2003). Because of the ease of homologous recombination and
haploid propagation in yeast, it has been possible to express
these mutated kinases without competition from its endogenous
wild-type counterpart. In mammalian cells, the use of the bump-
hole kinases as control elements has been limited largely to
those with dominant effects, such as in the oncogenes v-Src
and Fyn kinases (Bishop et al., 1999). The advent of facile
genome-editing techniques in metazoans should now allow
a fuller characterization of human kinases using the bump-hole
strategy.
The intuitively simple bump-hole strategy has also been
expanded to other classes of enzymes. Luo and colleagues
adapted the bump-hole strategy for protein (histone) methyl-
transferases (Luo, 2012). Protein methylation, like phosphoryla-
tion, can play an important part in a protein’s posttranslational
regulation. Epigenetic control through histone methylation in
particular is an important mode of gene expression regulation.
Luo and colleagues make use of S-adenosyl-L-methionine ana-
logs in conjunction with mutating conserved gatekeeper tyrosine
residues in the EuHMT1 and EuHMT2 methyltransferases to
identify their targets (Islam et al., 2013). This strategy should
be readily adaptable to control methyltransferase activity as
appropriate.Chemistry & Biology 21, September 18, 2014 ªEngineered Allosteric Control over
Protein Function
Naturally occurring allosteric control of
enzyme function drives functional regula-
tion of primary metabolism and manyother cellular processes (Gunasekaran et al., 2004). Small-mole-
cule or protein binding distal to the active site causes either a
conformational or dynamical change in the host protein, altering
its activity. In engineering allosteric regulation, researchers have
typically used one of two strategies (Figure 5). First, two protein
domains are fused together such that the folding of a control
domain affects the output of the second domain. Key factors
are the site of attachment and the length and flexibility linkers
used. Sites of attachment can be semiempirically determined
or computationally predicted. Second, an intramolecular binding
event can be switched to control the gross topology of the pro-
tein. The first approach requires sophisticated structural knowl-
edge and optimization but is in general more compact, whereas
the second strategy is often more modular in nature. Modular
assembly of several domains can even be used to control
input-output behavior of designed proteins.
An extreme case of designed allosteric regulation is the Loh
group’s mutually exclusive folding strategy (Radley et al.,
2003). From known structures, a protein domain is genetically in-
serted into a loop on the surface of the host protein. The relative
thermodynamic stability of the inserted domain determines
which of the two domains can fold: the loop can be pushed apart
if the inserted domain is more stable, disrupting the structure of
the host protein, or if the stability of the inserted domain is less
stable than the host protein, it will be unfolded. The relative
thermodynamic stability of the two domains can then be manip-
ulated by the addition of small- or large-molecule-binding part-
ners for each domain to create a bifunctional switchable protein
unit (Ha et al., 2006). Although mutually exclusive folding has
been used to engineer several switchable proteins, it has been
used only in vitro; its practical utility to control the function of
an arbitrary protein-of-interest remains to be established.
Engineered allosteric regulation can also affect a protein’s
activity without gross structural alteration. The focal adhesion
kinase G-loop governs the position of the incoming ATP; inser-
tion of an FKBP domain in a loop distal to the G-loop is thought
to increase the flexibility of the G-loop, interfering with the proper
catalytic activity of the kinase. Hahn and colleagues showed
that rapamycin mediated dimerization with an FRB domain
decreases the flexibility of this loop, restoring proper activity of
Fak (Karginov et al., 2010). Because of the high degree of con-
servation of kinases, this strategy may be generalizable without




Figure 5. Allosteric Control of Protein Function
(A) Mutually exclusive folding. One protein domain is inserted into an exterior
loop of another protein, creating mechanical stress on its structure. The in-
serted domain can become unfolded, relieving this stress, allowing the host
protein to fold properly. Thermodynamically controlling the stability of each of
the domains by the addition of ligands for either the host or inserted domain
can control the relative stability of the two domains.
(B) ‘‘Classic’’ allostery. Binding at a site distal to the active site causes a
conformational or dynamical change affecting the enzyme’s active site.
(C) Light-driven reversible intramolecular binding. Protein activity is seques-
tered by the close association of a Lov2 domain with the protein-of-interest.
Flexibility introduced by unfolding of the J-a helix allows protein activity.
Reversion is not controlled but relies on dark-state relaxation.
(D) Similar to (C), except the photoconvertible protein Dronpa allows direct
reversibility sequential application by violet (400 nm) or cyan (500 nm) light.
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domain is often used as a modular control unit in allosteric con-
trol strategies because of its small size and well-characterized
conformational change upon illumination with blue light. Sos-
nick and coworkers fused the Lov2 domain to the Escherichia
coli trp repressor at 12 different insertion points (Strickland
et al., 2008). One of these exhibited light-dependent DNA bind-
ing, though no functional studies were performed. The Hahn
group also used a Lov2 domain to control the function of several
small Rho-family GTPases (Wu et al., 2009). They found a Lov2-
constitutively active Rac1 fusion (photoactive-Rac1 [PA-Rac1])
that exhibited light-dependent binding to effector PAK. Again,
optimizing attachment points was key to finding light-depen-
dent activity of the fusion protein. Structural analysis and com-
parison with Cdc42 allowed the construction of a Lov2-fusion
photoactivatable analog, PA-Cdc42. The fast kinetics and
robust reversibility of PA-Rac1 allowed the Hahn group to tease
apart the hierarchy of signaling events in actin-dependent
membrane remodeling.1246 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier LtOptimization of insertion site and linker lengths have dramatic
effects on the success of allosteric regulation strategies but are
often empirically determined (Cutler et al., 2009). As an alterna-
tive to this, Ranganathan and coworkers used statistical
coupling analysis (SCA) to identify sectors connected to the sur-
face residues as targets for allosteric modulation (Lee et al.,
2008). SCA uses coevolution of amino acids within a protein to
identify functionally relevant ‘‘sectors’’ rather than structurally
defined protein ‘‘domains.’’ Fusing E. coli DHFR and Lov2
domain at these predicted sites produced a fusion protein whose
enzymatic activity could be modulated by 2-fold, leading to
measurable differences in growth rate of an auxotrophic E. coli
strain (Reynolds et al., 2011).
As an alternative to using Lov2 as the allosteric control
domain, the Lin lab recently showed that a Lys145Asn mutant
of the photoconvertible protein Dronpa undergoes reversible
oligomerization/dissociation upon illumination cyan or violet light
(Zhou et al., 2012). Inserting a tethered Dronpa 145N into the
Cdc42 GEF Dbl homology domain or HCV NS3-4A protease
rendered them light activatable. The kinetics of Dronpa 145N-
based control are somewhat slower than Lov2, but may be
easier to generalize and benefit from intrinsic fluorescence.
Protein Stability Control
Of the various methods for posttranslational control over protein
function, controlling its intracellular stability is most similar to
traditional genetic and transcription control methods. The pro-
tein-of-interest cannot be active if it is not there. Most conditional
protein degradation technologies take advantage of the ubiquitin
proteasome system (UPS) through intervention at several points
in the pathway (Figure 6). The UPS is a mechanism for the regu-
lated proteolysis of intracellular proteins. Proteins are targeted
for degradation if they are damaged or their activity interferes
with other cellular processes (Figure 6). Specific recognition
molecules tag the protein to be degraded by the conjugation to
ubiquitin. The addition of several ubiquitin molecules is typically
sufficient to target the protein to the proteasome, where it
is unfolded and processively degraded by the proteasome.
Proteins can be targeted for degradation using the cells’ natural
ubiquitylation machinery (N-end rule, destabilizing domains,
HaloTag-Hyt13) (Chu et al., 2008; Dohmen et al., 1994; Iwamoto
et al., 2010; Neklesa et al., 2011), via recruitment to specific ubiq-
uitin E3 ligases (PROTACs, LIDs, deGradFP, AID, ubiquibodies)
(Bonger et al., 2011, 2014; Caussinus et al., 2011; Nishimura
et al., 2009; Portnoff et al., 2014; Sakamoto et al., 2001), or
can bypass the ubiquitylation step altogether by small-mole-
cule-mediated direct recruitment to the proteasome (dimerizers,
degrons) (Janse et al., 2004; Renicke et al., 2013). Again, chem-
ical genetic protein stability control technologies are more easily
generalizable than those that rely solely on small-molecule-
mediated degradation but do not affect endogenous pools of
the protein-of-interest.
Historically, temperature-sensitive alleles of a particular gene
in yeast have been isolated that create conditional alleles of
gene of interest, but a new mutant needed to be found for
each gene being studied. In order to generalize this approach
to an arbitrary gene-of-interest, Dohmen and Varshavsky
created a tripartate fusion consisting of an N-end rule substrate,
a known temperature sensitive allele of (mouse) DHFR, and thed All rights reserved
AB
Figure 6. Degradation Mediated Control of Protein Abundance
(A) Schematic of the UPS. Normal proteins can be targeted for degradation by
their regulated ubiquitylation or if they are damaged or misfolded. Addition of a
minimum of four ubiquitin moieties targets the protein to the proteasome for
degradation.
(B) Each step in the UPS can be manipulated for regulated degradation of a
protein-of-interest. (i) Directly targeting a protein to the proteasome obviates
the need for ubiquitylation for degradation. (ii) Recruitment of an ubiquitin E3
ligase by the addition of a dimerizer causes ubiquitylation of the protein-of-
interest substrate, followed by its subsequent targeting to the proteasome and
degradation. (iii) Relying on natural ubiquitylation processes. Conditional
regulation of natural ubiquitylation processes by triggering the N-end rule or
recognition of destabilizing domains by protein quality control ubiquitin E3
ligases.
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evolutionarily conserved pathway that targets proteins with
certain N-terminal amino acids (Arg, Lys, etc.) for ubiquitylation
and degradation; to alter the N-terminal amino acid, they rely
on the rapid cleavage of linear ubiquitin fusion proteins by intra-
cellular deubiquitinating enzymes. Their temperature-sensitive
degron (td) technique used the conditional temperature accessi-
bility of the N-terminal arginine residue to control the intracellular
stability of Cdc28 and Ura3.
A significant advance to the robustness of this technique was
made by Labib and Diffley (Labib et al., 2000), who showed that
overexpression of the ubiquitin E3 ligase that facilitates the
N-end rule in yeast, Ubr1, can greatly increase the efficiency of
clearance of td-tagged substrates; inducible expression sys-
tems are used when possible to minimize potentially pleiotropic
effects of Ubr1. More than 100 genes have been tagged in thisChemistry & Biology 2manner. Because large changes in temperature can have pleio-
tropic effects, an isothermal method might be desirable. In order
to achieve this, Taxis and coworkers instead expressed a tripar-
tate fusion of a reporter-TEV target cut site-protein-of-interest
(Taxis et al., 2009). Coexpression of the TEV protease in these
cells causes cleavage and de novo exposure of the N-end rule
substrate and subsequent degradation of the fusion protein. It
should be noted that both these techniques also lowered the
expression of their target proteins prior to degradation by
altering the promoter used.
Because polyubiquitin chains target a protein to the protea-
some for degradation, directly controlling the recruitment of a
protein to the proteasome could also mediate its degradation.
Church and coworkers used a conditional dimerization system
to localize a Tor-His3 fusion to the proteasome by the addition
of rapamycin to cells expressing a Fpr1-Rpn10 fusion (Janse
et al., 2004). Localization of the proteasome caused fast degra-
dation of the His3 fusion protein. Degradation of His3 produced a
loss-of-function auxotrophic phenotype, though it was some-
what leaky. Another method to directly tether a protein-of-
interest to the proteasome is by fusing it to a fragment of
ornithine decarboxylase (ODC); GFP-ODC is constitutively
degraded in the absence of proteasome inhibition. Taxis and
coworkers fused ODC to the C-terminal J helix of Lov2 to pro-
duce a light-dependent conditional degradation signal (Renicke
et al., 2013). This modular degradation signal was able to confer
loss-of-function phenotypes to a variety of target proteins in
yeast but produced leaky phenotypes in some cases. In a similar
approach, our group concurrently showed that fusing a degron
to the C-terminal J helix of Lov2 could produce blue-light-depen-
dent conditional protein regulation in mammalian cells and in
zebrafish embryos (Bonger et al., 2014).
Instead of directly recruiting a protein-of-interest to the pro-
teasome, researchers have demonstrated that recruitment a
protein-of-interest to a ubiquitin E3 ligase is often sufficient to
drive its ubiquitylation and degradation. Crews and colleagues
first demonstrated in cell-free extracts that synthetic molecules,
called bifunctional proteolysis targeting chimeras (protacs), can
bind to both a target protein-of-interest, and a known E3 ligase is
sufficient to drive its degradation (Sakamoto et al., 2001). Several
other protac molecules have since been developed that allow
conditional degradation of particular target proteins in cells by
the addition of cell-penetrating peptides (Schneekloth et al.,
2004). Importantly, protacs allows the degradation of endoge-
nous proteins without the need for genetic manipulation, but its
use is limited to proteins with known small-molecule ligands
that can also be functionalized while retaining reasonable solubi-
lity and cell permeability. In another protac-like approach, Wang
and colleagues recently demonstrated that a bifunctional mole-
cule that binds to a protein-of-interest and acts as a signal for
chaperone mediated autophagy can also degrade proteins in a
proteasome independent manner (Fan et al., 2014). Although
there was still significant undegraded protein, this approach
could be very important in directing the degradation of proteins
under conditions of proteotoxic stress and insufficient protea-
some function.
If using a chemical genetic strategy, it should be possible to
simply fuse a known ligand-binding domain with a protein-of-
interest and use an established protac molecule. Analogously,1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1247
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called auxins to bridge the protein-of-interest with its target E3
ligase (Nishimura et al., 2009). A fusion of a protein-of-interest
with an auxin inducible degron could be ubiquitylated by coex-
pressing an adaptor F-box protein that also binds to SCF family
ubiquiting ligases in the presence of either of two synthetic
auxins, IAA or NAA. This yielded fast, tunable control in a variety
of experimental model systems.
Two recent reports also demonstrated degradation of a target
endogenous protein. In each case, single-chain Fv domains
that specifically bind to GFP are fused to either an F-box E3
ligase adaptor protein (Caussinus et al., 2011) or directly to
the promiscuous E3 ligase CHIP (Portnoff et al., 2014). When
these molecules are coexpressed with GFP fusion proteins,
the single-chain Fv binds to the GFP, which is subsequently
ubiquitylated by the E3 ligase and degraded by the proteasome.
Although these have been demonstrated only as genetically en-
coded engineered E3 ligases, it should be possible to combine
these with other conditional techniques highlighted here in order
to produce reversible control of the endogenous protein-of-
interest.
Intracellular protein folding is subject to strict quality control,
where misfolded or damaged proteins are targeted for ubiqui-
tylation and degradation. When attempting to control the activ-
ity of GSK3b in mice using a conditional dimerization system,
Crabtree and colleagues noticed that the GSK3b-FRBmutant
protein they were using was being degraded, but that could
be rescued by the addition of the small-molecule dimerizer
MaRap, with the additional recruitment of FKBP (Stankunas
et al., 2003). Indeed, Varshavsky and colleagues had previously
shown that methotrexate binds to and suppresses the degra-
dation of td-degron-tagged proteins (Johnston et al., 1995).
Our group then demonstrated that a genetically compact
system requiring only the expression of a protein-of-interest
fused to an unstable mutant of FKBP could be rescued by
the addition of the specific ligand Shield-1(Banaszynski et al.,
2006). These ‘‘destabilizing domains’’ conferred instability to
a variety of proteins through the processive degradation
at the proteasome. Destabilizing domains also conferred
tunable protein regulation in a several organisms, including in
living mice (Banaszynski et al., 2008; Iwamoto et al., 2010).
Using different protein-ligand pairs now allows the orthogonal
control of several proteins simultaneously in the same cell
(Iwamoto et al., 2010). Perhaps because of its modular and
generalizable uses, destabilizing domains have been widely
adopted (Armstrong and Goldberg, 2007; Brooks et al., 2010;
Campeau et al., 2009; Dolan et al., 2012; Dvorin et al., 2010;
Gong and de Lange, 2010; Kwan et al., 2011; Madeira da Silva
et al., 2009; Muralidharan et al., 2012; Pruett-Miller et al., 2009;
Raj et al., 2014). Some limitations to the use of destabilizing
domains remain, including the necessity for genetic manipula-
tion and mixed utility in the yeast S. cerevisiae (Rakhit et al.,
2011).
Where fusion of the destabilizing domain to the protein-of-in-
terest may interfere with its function, the protein-of-interest
may be combined with an excisable degron to release a free
complemented or unmodified protein. Although an intein could
be used for this purpose, Pratt and Muir and colleagues
exploited the propensity of linear ubiquitin fusions to be rapidly1248 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Lthydrolyzed by intracellular deubiquitinating enzymes (Pratt
et al., 2007). The protein-of-interest if fused to a degron, a dimer-
izer, and a ubiquitin fragment and expressed concurrently with a
second protein fused to the dimerization domain and the other
ubiquitin fragment. Upon dimerization and ubiquitin fragment
complementation, deubiquitinating enzymes cleave the dimer-
ization domains and ubiquitin to release the free, unmodified
protein-of-interest. Although it is not reversible and requires
dimerization, this system allows tunable control over the abun-
dance of a resultant unmodified (other than its N-terminal amino
acids) protein-of-interest (Lin and Pratt, 2014).
In theory, the application of genome-editing technology allows
site-specific addition of protein tags that enable many of the
posttranslational strategies outlined here. For example, it has
now been demonstrated that destabilizing domains can be in-
serted upstream of exon 1 of Treacher Collins-Franceschetti
syndrome-1 (TCOF1) to conditionally regulate it by the addition
of Shield-1 (Park et al., 2014). Because of the high efficiency of
gene targeting, both alleles can be modified in a single cell
leading to conditional regulation without interference from
endogenous sources. As the efficacy of gene editing techniques
improve, the conditional systems described above will become
more valuable to investigators who design control over biological
perturbations.
Future Directions and Outlook
The direct control of protein activity through chemical genetics
encapsulates many of the desirable properties of an ideal pertur-
bation strategy, including specificity, speed, reversibility, and
tunability; however, they also present unique limitations. For
example, the direct regulation of an engineered protein has
been demonstrated in several cases but can require substantial
investment in optimization for the particular protein being
studied. Conditional dimerization techniques offer significant
advantages in speed compared with degradation tools but are
limited to those proteins with subcellular compartment-specific
activity. Degradation-based systems are more generally appli-
cable but are somewhat slower and limited to proteins with
access to the proteasome.
When choosing an experimental perturbation strategy, a
researcher must weigh the precision that an experiment requires
against the available tools. Chemical genetic approaches to
posttranslationally control protein activity combine the strengths
of biologically active small molecules and the specificity of
genetic manipulation without having to screen for a particular
small molecule. As alluded to earlier, a primary concern with
any manipulation, especially in the context of protein-level
control, is the robustness of the technology. Although genetic
deletion is slow, cumbersome, and spatiotemporally imprecise,
it remains the gold standard for many biologists in understanding
a gene’s function, because it yields unambiguous results. The
burden of proof falls on the chemical biology community to
improve the robustness of posttranslational, protein-level pertur-
bation technologies to move them from niche to more main-
stream biological applications, as seen with ligand-inducible
transcriptional systems.
Although the past few years have witnessed tremendous
advances in the breadth of protein control technologies, more
specific manipulations are desirable. An area that has seend All rights reserved
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tional modifications. Because kinases, phosphatases, and so
on, may have many downstream targets, regulating their activity
does not allow careful dissection of these networks. When
posttranslational modifications are present, it is not clear
which modification, and in which contexts, are biologically
relevant to the control of that protein’s activity. In order to study
this, biologists currently make phosphoanalog mutants by re-
placing a serine, threonine, or tyrosine residue with one of the
negatively charged amino acids, such as aspartic or glutamic
acid. Although combining a phospho mutant with an established
conditional protein regulation tool may provide more precise
control of this target, the perturbation is likely to be slow relative
to the timescale of the biological process under study, such as its
downstream signaling or its role in chromatin remodeling. Amore
elegant solution would enable the study of these biologically
important processes.
Another key area of potential improvement to these chemi-
cal genetic tools is in experimental systems in which fewer
tools are available. First, conditional tools to study mitochon-
drial or extracellular proteins remain relatively underexplored
(Sellmyer et al., 2012). Strategies that target these proteins
for degradation are also lacking, largely because they are
compartmentally sequestered from the proteasome. The study
of clinically relevant apicomplexan parasites, such as Toxo-
plasma gondii and the Plasmodium species, is limited by the
availability of conditional techniques to control essential pro-
tein function, because they are haploid. Destabilizing domains
have been used to conditionally degrade proteins in these
organisms, but have not been as effective as they are in
mammalian cells (Jimanez-Ruiz et al., 2014). The development
of improved conditional protein regulation systems would
allow more efficient characterization of protein signaling in
these organisms.
Moving beyond these specific applications, one aspect of
these conditional control systems remains to be exploited,
which is their ability to deepen our mechanistic understanding
of biological systems. In theory, the speed and specificity these
technologies offer should help control for any cellular compen-
satory mechanisms leading to an observable phenotype; how-
ever, the timescale at which most of these tools operate lags
behind the speed of signaling processes in vivo, which can still
complicate quantitative assessments. More generally, mecha-
nistic studies are further complicated by the fact that the
most well-characterized and commonly used tools are far
from ideal. A case in point here is the use of rapamycin-based
approaches, which continue to be implemented today. This ul-
timately highlights the need for significantly improved, general
small-molecule-based tools. Another factor that complicates
in-depth biological studies is that a given protein may have
more than one function or binding partner, which would be diffi-
cult to identify using current technologies. Although the parallel
application of these tools—to study multiple proteins in a single
system—can help elucidate such confounding factors, such
studies may be difficult to execute from a practical standpoint.
The development of efficient and practical ways to simulta-
neously study multiple proteins will ultimately give us a more
quantitative look at the interactions that orchestrate complex
biological behavior.Chemistry & Biology 2SUPPLEMENTAL INFORMATION
Supplemental Information includes two tables and can be found with this
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